v3.22.2.2
Collaboration and License Agreements - Horizon Therapeutics Ireland DAC (Details)
12 Months Ended
Jun. 18, 2021
USD ($)
obligation
bundle
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Jul. 31, 2021
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Revenues   $ 243,231,000 $ 138,287,000 $ 87,992,000  
Contract liabilities   74,099,000 111,055,000    
Horizon Therapeutics Ireland DAC | ARO-XDH          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Cash received as due under collaboration agreement         $ 40,000,000
Number of distinct performance obligations | obligation 1        
Initial transaction price $ 40,000,000        
Revenues   26,700,000 6,700,000    
Contract assets   0      
Contract liabilities   6,700,000      
Horizon Therapeutics Ireland DAC | License Agreement          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Number of distinct bundle | bundle 1        
Number of distinct performance obligations | obligation 1        
Horizon Therapeutics Ireland DAC | ARO-XDH Supply Agreement          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Revenues   2,500,000 $ 0    
Contract assets   1,300,000      
Contract liabilities   $ 0      
Horizon Therapeutics Ireland DAC | Maximum | ARO-XDH          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Development regulatory and sales milestones payments $ 660,000,000